Your browser doesn't support javascript.
loading
Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
Isozaki, Hideko; Sakhtemani, Ramin; Abbasi, Ammal; Nikpour, Naveed; Stanzione, Marcello; Oh, Sunwoo; Langenbucher, Adam; Monroe, Susanna; Su, Wenjia; Cabanos, Heidie Frisco; Siddiqui, Faria M; Phan, Nicole; Jalili, Pégah; Timonina, Daria; Bilton, Samantha; Gomez-Caraballo, Maria; Archibald, Hannah L; Nangia, Varuna; Dionne, Kristin; Riley, Amanda; Lawlor, Matthew; Banwait, Mandeep Kaur; Cobb, Rosemary G; Zou, Lee; Dyson, Nicholas J; Ott, Christopher J; Benes, Cyril; Getz, Gad; Chan, Chang S; Shaw, Alice T; Gainor, Justin F; Lin, Jessica J; Sequist, Lecia V; Piotrowska, Zofia; Yeap, Beow Y; Engelman, Jeffrey A; Lee, Jake June-Koo; Maruvka, Yosef E; Buisson, Rémi; Lawrence, Michael S; Hata, Aaron N.
Affiliation
  • Isozaki H; Massachusetts General Hospital Cancer Center, Boston, MA, USA. hisozaki@mgh.harvard.edu.
  • Sakhtemani R; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. hisozaki@mgh.harvard.edu.
  • Abbasi A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Nikpour N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Stanzione M; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Oh S; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Langenbucher A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Monroe S; Department of Biological Chemistry, Center for Epigenetics and Metabolism, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
  • Su W; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Cabanos HF; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Siddiqui FM; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Phan N; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Jalili P; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Timonina D; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Bilton S; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Gomez-Caraballo M; Department of Biological Chemistry, Center for Epigenetics and Metabolism, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
  • Archibald HL; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Nangia V; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Dionne K; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Riley A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Lawlor M; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Banwait MK; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Cobb RG; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Zou L; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Dyson NJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Ott CJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Benes C; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Getz G; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Chan CS; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
  • Shaw AT; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Lin JJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Sequist LV; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Piotrowska Z; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Yeap BY; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Engelman JA; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Lee JJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Maruvka YE; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Buisson R; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Lawrence MS; Department of Pathology, Harvard Medical School, Boston, MA, USA.
  • Hata AN; Department of Medicine, Rutgers Robert Wood Johnson Medical School and Center for Systems and Computational Biology, Rutgers Cancer Institute, New Brunswick, NJ, USA.
Nature ; 620(7973): 393-401, 2023 Aug.
Article de En | MEDLINE | ID: mdl-37407818
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cytidine deaminase / Tumeurs du poumon Limites: Humans Langue: En Journal: Nature Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cytidine deaminase / Tumeurs du poumon Limites: Humans Langue: En Journal: Nature Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique